Back
Apellis Pharmaceuticals Quote, Financials, Valuation and Earnings
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Buy
51
APLS
Apellis Pharmaceuticals
Last Price:
29.96
Seasonality Move:
22.1%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!Apellis Pharmaceuticals Price Quote
$29.96
-0.06 (4.25%)
(Updated: November 9, 2024 at 5:12 AM ET)
Apellis Pharmaceuticals Key Stats
Buy
51
Apellis Pharmaceuticals (APLS)
is a Buy
Day range:
$28.51 - $30.14
52-week range:
$24.34 - $73.80
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
5.17
P/B ratio:
15.75%
Volume:
2.5M
Avg. volume:
3.4M
1-year change:
-36.11%
Market cap:
$3.7B
Revenue:
$396.6M
EPS:
$-2.03
How Much Does Apellis Pharmaceuticals Make?
-
How Much Are Apellis Pharmaceuticals's Sales Annually?
APLS Revenues are $396.6M -
How Much Profit Does Apellis Pharmaceuticals's Make A Year?
APLS net income is -$528.6M
Is Apellis Pharmaceuticals Growing As A Company?
-
What Is Apellis Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.78% -
What Is Apellis Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Apellis Pharmaceuticals Stock Price Performance
-
Did Apellis Pharmaceuticals Stock Go Up Last Month?
Apellis Pharmaceuticals share price went up by 9.56% last month -
Did APLS's Share Price Rise Over The Last Year?
APLS share price fell by -36.11% over the past 1 year
What Is Apellis Pharmaceuticals 52-Week High & Low?
-
What Is Apellis Pharmaceuticals’s 52-Week High Share Price?
Apellis Pharmaceuticals has traded as high as $73.80 over the past 52 weeks -
What Is Apellis Pharmaceuticals’s 52-Week Low Share Price?
Apellis Pharmaceuticals has traded as low as $24.34 over the past 52 weeks
Apellis Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Apellis Pharmaceuticals?
-
How Much Debt Does Apellis Pharmaceuticals Have?
Total long term debt quarterly is $452.2M -
How Much Cash Does Apellis Pharmaceuticals Have?
Cash and short term investments quarterly total is $396.9M -
What Is Apellis Pharmaceuticals’s Book Value Per Share?
Book value per share is 1.94
Is Apellis Pharmaceuticals Cash Flow Positive?
-
What Is APLS Cash Flow From Operations?
Cash flow from operations (TTM) is -$205.1M -
What Is Apellis Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $149.3M -
What Is Apellis Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$379K
Apellis Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
APLS return on invested capital is -52.47% -
What Is Apellis Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -29.46% -
What Is APLS Return On Equity?
ROE is a measure of profitability and is -104.65%
Apellis Pharmaceuticals Earnings Date & Stock Price
-
What Is Apellis Pharmaceuticals's Stock Price Today?
A single share of APLS can be purchased today for 30.02 -
What Is Apellis Pharmaceuticals’s Stock Symbol?
Apellis Pharmaceuticals trades on the nasdaq under the ticker symbol: APLS -
When Is Apellis Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Apellis Pharmaceuticals is scheduled on February 27, 2025 -
When Is APLS's next ex-dividend date?
Apellis Pharmaceuticals's next ex-dividend date is November 11, 2024 -
How To Buy Apellis Pharmaceuticals Stock?
You can buy Apellis Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Apellis Pharmaceuticals Competitors
-
Who Are Apellis Pharmaceuticals's Competitors?
Below is a list of companies who compete with Apellis Pharmaceuticals or are related in some way:
Apellis Pharmaceuticals Dividend Yield
-
What Is APLS Dividend Yield?
Apellis Pharmaceuticals’s dividend yield currently is 0% -
What Is Apellis Pharmaceuticals’s Payout Ratio?
Apellis Pharmaceuticals’s payout ratio is 0% -
When Did Apellis Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is November 11, 2024 -
What Is Apellis Pharmaceuticals’s Dividend Per Share?
Apellis Pharmaceuticals pays a dividend of $0.00 per share
Apellis Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -71.42% |
| Revenue: | 78.29% | -1.5% |
Analyst Recommendations
| Buy Recommendations: | 11 |
|---|---|
| Hold Recommendations: | 6 |
| Sell Recommendations: | 0 |
| Price Target: | 46.79 |
| Upside from Last Price: | 55.86% |